smv simeprevir (BOC Sciences)
Structured Review
Smv Simeprevir, supplied by BOC Sciences, used in various techniques. Bioz Stars score: 91/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simeprevir+smv/Simeprevir/pm32303953-102-297-250
Average 91 stars, based on 9 article reviews
Images
Related Articles
other:Article Title: UEG Week 2016 Poster Presentations Article Snippet: Patients with contraindications to HCV agents due to DDIs were 30 (6.0%) for paritaprevir/ritonavir/ombitasvir ± dasabuvir (3D/2D), 26 (5.2%) for Article Title: Decreased Expression of Vitamin D Receptor May Affect an Immune Response Via VDR – MIRNA 155 - SOCS1 Pathway in Primary Biliary Cirrhosis Article Snippet: FRI-344 DECREASED EXPRESSION OF VITAMIN D RECEPTOR MAY AFFECT AN IMMUNE RESPONSE VIAVDR – MIRNA155 SOCS1 PATHWAY IN PRIMARY BILIARY CIRRHOSIS A.K.. Podhorodecka, U. Wasik, P. Milkiewicz, M. Milkiewicz.. Department of Medical Biology Laboratory, Pomeranian Medical University, Szczecin; Liver and Internal Medicine Unit, Medical University of Warsaw, Warsaw; Department of Clinical and Molecular Biochemistry, Pomeranian Medical University, Szczecin, Poland E-mail: agnieszkakempinska@interia.eu Article Title: UEG Week 2016 Poster Presentations Article Snippet: Patients with contraindications to HCV agents due to DDIs were 30 (6.0%) for paritaprevir/ ritonavir/ombitasvir dasabuvir (3D/2D), 26 (5.2%) for |

